The wins, which are the first for S&H India, include Johnson & Johnson’s Stapler account and Galderma Labs, a pharmaceutical company formed as a joint-venture between Nestlé and L’Oréal.
The two accounts are collectively worth about Rs 20 crore (US$4.8 million).
The Johnson & Johnson win comes just ahead of a launch of a surgical product by the company in India. “The product’s details are confidential, but we are working on the product brand across India at this point of time and later plan to expand it to China and Russia as well,” said Asha Kapooer, executive director, S&H India.
The campaign, expected to break shortly, will comprise various below-the-line initiatives, such as medical education and interactive sessions, along with an integrated above-the-line campaign.
The pitch, called in February, also included Lowe Healthcare and Ogilvy Healthcare.
For Galderma Labs, S&H will handle the relaunch and creative duties of the Cetaphil skin care brand’s over-the-counter products. “We are working on a multi-dimensional campaign for the relaunch of this cleanser,” said Kapooer.
“As one campaign will run across different countries, we will be working closely with individual markets in order to come up with the desired solution.”
